Translate scientific discovery into value and practical public health interventions.
Centered on a One Health framework, ITR will integrate human, animal, and environmental health perspectives to develop and implement joint activities, including validation of molecular biomarkers and the establishment of genomic and metagenomic surveillance systems to monitor antimicrobial and insecticide resistance.
PRIME and VBD will lead the molecular and field components, CTM will manage clinical validation and translational studies that include the design, testing, and implementation of PoC diagnostic tools (e.g DxHub One Health @ PoC), the validation of molecular biomarkers, and the establishment of genomic and metagenomic surveillance systems to monitor antimicrobial and insecticide resistance, and PPS will ensure integration into health systems and policies.
ITR will also promote the implementation of science and capacity building by engaging communities, policymakers, industry, and healthcare professionals.
Collaborative training programs, workshops, and mentorship activities will enhance research translation, while interdisciplinary publications, innovation pipelines, and policy briefs will ensure that scientific outputs inform evidence-based interventions.
Through these cross-cutting activities, the ITR program will reinforce GHTM’s leadership in translational research, accelerating the transformation of scientific knowledge into impactful and sustainable global health solutions.
Recent Highlights
Jornadas GHTM 2026 Debates the Future of Global Health Through the Lens of One Health and Mobility
Experts and health professionals gathered at IHMT NOVA to discuss One Health, mobility, AI, climate change, and Global Health challenges.
Read More
World Malaria Day 2026: Exploring Innovative Vector Control Strategies for a Changing Global Landscape
Discover how GHTM researchers are advancing sustainable malaria prevention through innovative Bloodless mosquito control technology.
Read More
Facilitator
